Below are the most recent publications written about "Retinal Neoplasms" by people in Profiles.
-
He D, Huang X, Uppal K, Coleman AL, Walker DD, Ritz B, Jones DP, Heck JE. BIOMARKERS OF MATERNAL SMOKING AND THE RISK OF RETINOBLASTOMA IN OFFSPRING. Retina. 2023 03 01; 43(3):481-489.
-
Omidakhsh N, Hansen J, Ritz B, Coleman AL, McKean-Cowdin R, Olsen J, Heck JE. Parental Occupation and Risk of Childhood Retinoblastoma in Denmark. J Occup Environ Med. 2021 03 01; 63(3):256-261.
-
Guihurt Santiago J, Burgos-Tirado N, Lafontaine DD, Mendoza Sierra JC, Camacho RH, Vecchini Rodr?guez CM, Morales-Tirado V, Flores-Otero J. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion. BMC Cancer. 2021 Jan 11; 21(1):53.
-
Goldsmith ZK, Coppess W, Irvine AS, Yuan K, Barsh SR, Ritter MK, McEwen MW, Flores-Otero J, Garcia-Vargas A, Martinez-Ferrer M, Brennan RC, Morales-Tirado VM, Wilson MW. Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds. Invest Ophthalmol Vis Sci. 2018 09 04; 59(11):4486-4495.
-
Montoya V, Fan H, Bryar PJ, Weinstein JL, Mets MB, Feng G, Martin J, Martin A, Jiang H, Laurie NA. Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation. PLoS One. 2015; 10(9):e0138366.
-
Martin J, Bryar P, Mets M, Weinstein J, Jones A, Martin A, Vanin EF, Scholtens D, Costa FF, Soares MB, Laurie NA. Differentially expressed miRNAs in retinoblastoma. Gene. 2013 Jan 10; 512(2):294-9.
-
Brennan RC, Federico S, Bradley C, Zhang J, Flores-Otero J, Wilson M, Stewart C, Zhu F, Guy K, Dyer MA. Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a. Cancer Res. 2011 Jun 15; 71(12):4205-13.
-
Laurie N, Mohan A, McEvoy J, Reed D, Zhang J, Schweers B, Ajioka I, Valentine V, Johnson D, Ellison D, Dyer MA. Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Mol Cell Biol. 2009 Dec; 29(23):6268-82.
-
Laurie NA, Shih CS, Schin-Shih C, Dyer MA. Targeting MDM2 and MDMX in retinoblastoma. Curr Cancer Drug Targets. 2007 Nov; 7(7):689-95.
-
Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C, Dyer MA. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res. 2005 Oct 15; 11(20):7569-78.